alexa Abstract | Evaluation of Four Tumor-Specific Promoters in Various Cancer Cell Lines

Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article Open Access


Specific tumor cell targeting remains a challenge for cancer gene therapy. One strategy in overcoming this challenge is by using tumorspecific promoters to drive the expression of delivered genes selectively in cancer cells. In this study, we selected 5′-upstream promoters of survivin, high-mobility group protein B2 (HMGB2), cyclooxygenase-2 (cox-2) and alpha-lactalbumin (LALBA), which have been observed to be significantly upregulated in tumors but have a low level of expression in normal tissues. Plasmid DNA coding for the Discosoma sp. red fluorescent protein (DsRed) under control of the selected promoters were constructed. The activities of these promoters in cancer cell line models of breast cancer (MCF-7 and MDA-MB-231), glioblastoma (U-87 MG and C6), and medulloblastoma (DAOY) were assessed by flow cytometry and a microplate-reader assay. The promoter of cox-2 exhibited the highest transfection efficiency and activity among all the tested promoters, suggesting its broad applicability among multiple cancer types. Furthermore, the LALBA promoter showed the highest selectivity for breast cancer and medulloblastoma. These results should provide a framework for the further development of highly specific and active promoters for targeted cancer gene therapy.

To read the full article Peer-reviewed Article PDF image

Author(s): Kui Wang, Forrest M Kievit and Miqin Zhang


Tumor-Specific Promoters, Cancer Cell Lines, Cyclooxygenase-2, Non-viral gene delivery vehicles, Pharmaceutical Technology, Biopharmaceutics, Molecular Drug Design

Recommended Journals

Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version